209 related articles for article (PubMed ID: 396660)
1. Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects.
Bianchi Porro G; Prada A; Petrillo M; Grossi M
Scand J Gastroenterol Suppl; 1979; 57():63-7. PubMed ID: 396660
[TBL] [Abstract][Full Text] [Related]
2. Pirenzepine in the treatment of duodenal ulcer.
D'Imperio N; Giuliani Piccari G; Lepore AM; Sarti F; Dal Monte PR
Scand J Gastroenterol Suppl; 1979; 57():41-4. PubMed ID: 396656
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, short-term clinical trial of pirenzepine in duodenal ulcer.
Morelli A; Narducci F; Pelli MA; Spadacini A
Scand J Gastroenterol Suppl; 1979; 57():45-9. PubMed ID: 396657
[TBL] [Abstract][Full Text] [Related]
4. Pirenzepine versus cimetidine in the treatment of duodenal ulcer.
Bianchi Porro G; Petrillo M; Lazzaroni M; Dal Monte PR; D'Imperio N; Giuliani Piccari G
Scand J Gastroenterol Suppl; 1979; 57():59-62. PubMed ID: 396659
[TBL] [Abstract][Full Text] [Related]
5. Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial, First of two parts.
Barbara L; Belsasso E; Bianchi Porro G; Blasi A; Caenazzo E; Chierichetti SM; Di Febo G; Di Mario F; Farini R; Giorgi-Conciato M; Grossi E; Mangiameli A; Miglioli M; Naccarato R; Petrillo M
Scand J Gastroenterol Suppl; 1979; 57():11-5. PubMed ID: 396651
[TBL] [Abstract][Full Text] [Related]
6. Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial. Second of two parts.
Barbara L; Belsasso E; Bianchi Porro G; Blasi A; Caenazzo E; Di Febo G; Di Mario F; Farini R; Giorgi-Conciato M; Mangiameli A; Miglioli M; Naccarato R; Petrillo M
Scand J Gastroenterol Suppl; 1979; 57():17-9. PubMed ID: 396652
[TBL] [Abstract][Full Text] [Related]
7. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
Oselladore D; Chierichetti SM; Norberto L; Vibelli C
Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
[TBL] [Abstract][Full Text] [Related]
8. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
Petrillo M; Bianchi Porro G
Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
[TBL] [Abstract][Full Text] [Related]
9. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F
Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149
[TBL] [Abstract][Full Text] [Related]
10. Pirenzepine in the treatment of gastric ulcer. A double-blind short-term clinical trial.
Morelli A; Pelli A; Narducci F; Spadacini A
Scand J Gastroenterol Suppl; 1979; 57():51-5. PubMed ID: 396658
[TBL] [Abstract][Full Text] [Related]
11. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease.
Jaup BH; Stockbrügger R; Dotevall G
Scand J Gastroenterol; 1979; 14(5):621-4. PubMed ID: 493866
[TBL] [Abstract][Full Text] [Related]
12. The influence of various secretory inhibitors on peptic activity.
Gabryelewicz A; Laszewicz W; Sarosiek J
Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
[TBL] [Abstract][Full Text] [Related]
13. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a defective inhibition of pentagastrin-stimulated gastric acid secretion by antral distension in the duodenal ulcer patient.
Schöön IM; Bergegårdh S; Grötzinger U; Olbe L
Gastroenterology; 1978 Sep; 75(3):363-7. PubMed ID: 680489
[TBL] [Abstract][Full Text] [Related]
15. Treatment and relapse prophylaxis of duodenal ulcer with pirenzepine and cimetidine.
Eichenberger PM; Giger M; Mattle W; Pelloni S; Müller-Lissner SA; Gonvers JJ; Birchler R; Blum AL
Scand J Gastroenterol Suppl; 1982; 72():197-205. PubMed ID: 6753114
[TBL] [Abstract][Full Text] [Related]
16. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
[TBL] [Abstract][Full Text] [Related]
17. Pirenzepine in the treatment of benign gastroduodenal diseases. A double-blind controlled clinical trial.
Gasbarrini G; Giorgi-Conciato M; D'Anchino M; Di Tommaso B; Pesa O; Sollecito A; Cifani G
Scand J Gastroenterol Suppl; 1979; 57():25-31. PubMed ID: 396654
[TBL] [Abstract][Full Text] [Related]
18. The effect of different doses of pirenzepine on gastric secretion stimulated by modified shamfeeding in man.
Stockbrügger RW; Jaup BH; Dotevall G
Scand J Gastroenterol Suppl; 1982; 72():111-7. PubMed ID: 6957978
[TBL] [Abstract][Full Text] [Related]
19. The effect of intragastric pH-variations on the gastric acid response to insulin hypoglycaemia in healthy subjects and duodenal ulcer patients.
Stenquist B; Knutson U; Rehnberg O; Olbe L
Scand J Gastroenterol; 1977; 12(2):169-75. PubMed ID: 15311
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease.
Mahachai V; Reilly P; Thomson AB
Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
